ARID3A Antibodies

Santa Cruz Biotechnology delivers a wide array of ARID3A monoclonal antibodies for investigating ARID3A protein function. ARID3A monoclonal antibodies are validated for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). ARID3A, a member of the AT-rich interaction domain family, plays a crucial role in regulating gene expression and is involved in processes such as cell differentiation and immune response. ARID3A's significance extends to its association with various diseases, including cancer, where it influences tumor progression and metastasis. Understanding ARID3A function is essential for developing new therapeutic strategies. Researchers worldwide rely on ARID3A monoclonal antibodies to explore cellular pathways and molecular mechanisms. Advanced research techniques using ARID3A monoclonal antibodies enable precise detection and analysis of protein expression patterns. ARID3A monoclonal antibodies from Santa Cruz Biotechnology support cutting-edge research that advances scientific understanding of cellular processes and disease mechanisms.